Left Atrial Appendage Exclusion Study — PLACE II

Atrial Appendage Clinical Trial

Official title:
Left Atrial Appendage Exclusion Study II

Status Completed

Clinical Trial Summary

Evaluate the safety and effectiveness of the LARIAT Suture Delivery device in excluding the left atrial appendage in 100 patients.

Clinical Trial Description

The objective of this study is to evaluate the safety and effectiveness of the SentreHEART suture delivery system for the exclusion of the left atrial appendage in up to 100 treated patients. ;

Study Design

Related Conditions & MeSH terms

Atrial Appendage

Clinical Trial Details

NCT number	NCT01983605
Study type	Interventional
Source	AtriCure, Inc.
Contact
Status	Completed
Phase	N/A
Start date	December 2009
Completion date	December 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03273322` - Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure	Phase 2/Phase 3
Recruiting	`NCT04796714` - AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE	Phase 4
Completed	`NCT02059707` - LARIAT RS: An Observational Study of the Performance and Safety of the LARIAT RS	N/A
Not yet recruiting	`NCT05263024` - Study on the Significance of Auricular Clip in Prevention and Treatment of Valvular Heart Disease Atrial Thrombosis